Free Trial
→ Why Peter Thiel Hid Gold in a Vault (From Golden Portfolio) (Ad)tc pixel Free CHCT Stock Alerts

Community Healthcare Trust (CHCT) Financials

Community Healthcare Trust logo
$15.36 +0.13 (+0.82%)
As of 02:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Community Healthcare Trust

Annual Income Statements for Community Healthcare Trust

This table shows Community Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 22 7.71 -3.18
Consolidated Net Income / (Loss)		 22 7.71 -3.18
Net Income / (Loss) Continuing Operations		 22 7.71 -3.18
Total Pre-Tax Income 		22 8.02 -3.18
Total Revenue		 86 96 93
Net Interest Income / (Expense)		 -12 -17 -23
Total Interest Income		 0.07 0.81 0.53
Other Interest Income		 0.07 0.81 0.53
Total Interest Expense		 12 18 24
Long-Term Debt Interest Expense		 12 18 24
Total Non-Interest Income		 98 113 116
Other Service Charges		 3.58 4.16 1.22
Other Non-Interest Income		 94 109 115
Provision for Credit Losses		 0.00 0.00 11
Total Non-Interest Expense		 64 88 85
Property & Liability Insurance Claims		 17 21 23
Other Operating Expenses		 15 27 19
Depreciation Expense		 32 40 43
Impairment Charge		 0.00 0.10 0.12
Income Tax Expense		 0.04 0.31 0.00
Basic Earnings per Share		 $0.81 $0.20 ($0.23)
Weighted Average Basic Shares Outstanding		 23.63M 25.20M 26.53M
Diluted Earnings per Share		 $0.81 $0.20 ($0.23)
Weighted Average Diluted Shares Outstanding		 23.63M 25.20M 26.53M
Weighted Average Basic & Diluted Shares Outstanding		 26.02M 27.68M 28.34M
Cash Dividends to Common per Share		 $1.77 $1.81 $1.85

Quarterly Income Statements for Community Healthcare Trust

This table shows Community Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 5.67 5.24 -6.92 6.58 3.49 4.57 3.67 -10 1.75 1.83
Consolidated Net Income / (Loss)		 5.67 5.24 -6.92 6.58 3.49 4.57 3.67 -10 1.75 1.83
Net Income / (Loss) Continuing Operations		 5.67 5.22 -6.92 6.58 3.49 4.57 3.67 -10 1.75 1.83
Total Pre-Tax Income 		5.69 2.63 -6.89 6.63 3.82 4.47 3.67 -10 1.74 1.84
Total Revenue		 22 22 23 24 24 24 24 28 30 11
Net Interest Income / (Expense)		 -3.02 -3.46 -3.97 -3.39 -4.64 -4.98 -5.06 0.31 0.21 -19
Total Interest Income		 0.01 0.00 0.03 0.75 0.00 0.04 0.00 0.31 0.21 0.02
Total Interest Expense		 3.03 3.46 3.99 4.14 4.64 5.02 5.06 0.00 0.00 19
Total Non-Interest Income		 25 25 27 28 29 29 29 28 30 29
Other Service Charges		 0.89 0.96 1.05 1.05 1.05 1.02 0.99 -0.39 0.30 0.32
Other Non-Interest Income		 24 24 26 27 28 28 28 28 29 29
Total Non-Interest Expense		 16 17 30 18 20 20 21 21 22 21
Property & Liability Insurance Claims		 4.33 4.16 4.87 4.79 5.46 5.60 5.79 5.57 5.99 5.49
Other Operating Expenses		 3.76 4.15 16 3.79 3.62 3.73 4.55 4.76 4.94 4.81
Depreciation Expense		 8.00 8.32 9.02 9.22 11 10 10 11 11 11
Basic Earnings per Share		 $0.21 $0.18 ($0.32) $0.24 $0.11 $0.17 $0.11 ($0.42) $0.04 $0.04
Weighted Average Basic Shares Outstanding		 23.59M 23.63M 24.23M 25.07M 25.51M 25.20M 26.30M 26.48M 26.66M 26.53M
Diluted Earnings per Share		 $0.21 $0.18 ($0.32) $0.24 $0.11 $0.17 $0.11 ($0.42) $0.04 $0.04
Weighted Average Diluted Shares Outstanding		 23.59M 23.63M 24.23M 25.07M 25.51M 25.20M 26.30M 26.48M 26.66M 26.53M
Weighted Average Basic & Diluted Shares Outstanding		 25.30M 26.02M 26.30M 26.56M 27.26M 27.68M 27.70M 28.06M 28.24M 28.34M

Annual Cash Flow Statements for Community Healthcare Trust

This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 9.20 -7.44 -0.25
Net Cash From Operating Activities		 60 61 59
Net Cash From Continuing Operating Activities		 60 61 59
Net Income / (Loss) Continuing Operations		 22 7.71 -3.18
Consolidated Net Income / (Loss)		 22 7.71 -3.18
Provision For Loan Losses		 0.00 0.00 11
Depreciation Expense		 32 40 43
Amortization Expense		 0.85 13 0.93
Non-Cash Adjustments to Reconcile Net Income		 6.01 4.82 8.17
Changes in Operating Assets and Liabilities, net		 -0.94 -3.39 -0.81
Net Cash From Investing Activities		 -114 -114 -93
Net Cash From Continuing Investing Activities		 -113 -114 -92
Purchase of Property, Leasehold Improvements and Equipment		 -10 -19 -25
Purchase of Investment Securities		 -106 -101 -75
Sale and/or Maturity of Investments		 3.00 6.19 7.42
Other Investing Activities, net		 0.67 - 0.22
Net Cash From Financing Activities		 63 45 34
Net Cash From Continuing Financing Activities		 63 45 34
Issuance of Debt		 150 50 162
Issuance of Common Equity		 21 44 7.49
Repayment of Debt		 -63 -0.13 -83
Payment of Dividends		 -44 -48 -52
Other Financing Activities, Net		 -0.39 -1.19 -1.01
Cash Interest Paid		 11 18 23

Quarterly Cash Flow Statements for Community Healthcare Trust

This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 0.98 8.73 -7.44 -0.95 1.26 -0.30 0.31 -4.21 2.10 1.55
Net Cash From Operating Activities		 15 15 13 17 18 14 13 17 14 16
Net Cash From Continuing Operating Activities		 15 15 13 17 18 14 13 17 14 16
Net Income / (Loss) Continuing Operations		 5.67 5.24 -6.92 6.58 3.49 4.57 3.67 -10 1.75 1.83
Consolidated Net Income / (Loss)		 5.67 5.24 -6.92 6.58 3.49 4.57 3.67 -10 1.75 1.83
Depreciation Expense		 8.00 8.32 9.02 9.22 11 10 10 11 11 11
Amortization Expense		 0.21 0.23 12 0.24 0.05 0.19 0.22 0.17 0.25 0.29
Non-Cash Adjustments to Reconcile Net Income		 1.63 1.81 1.67 0.22 1.78 1.16 1.67 2.81 1.81 1.87
Changes in Operating Assets and Liabilities, net		 -0.16 -0.18 -3.13 0.42 1.19 -1.87 -3.17 2.38 -0.90 0.87
Net Cash From Investing Activities		 -22 -58 -29 -16 -55 -14 -39 -30 -14 -9.49
Net Cash From Continuing Investing Activities		 -22 -57 -29 -16 -55 -14 -39 -30 -14 -9.43
Purchase of Property, Leasehold Improvements and Equipment		 -3.05 -3.68 -4.14 -3.75 -3.58 -7.52 -5.11 -7.19 -7.19 -5.16
Purchase of Investment Securities		 -20 -55 -25 -17 -52 -6.90 -34 -24 -8.91 -8.42
Sale and/or Maturity of Investments		 0.75 0.75 0.75 3.78 0.79 0.87 0.87 0.75 1.72 4.09
Other Investing Activities, net		 - - - - - - 0.03 0.05 0.08 0.06
Net Cash From Financing Activities		 7.73 51 8.44 -1.15 39 -1.04 26 9.32 2.64 -4.63
Net Cash From Continuing Financing Activities		 7.73 51 8.44 -1.15 39 -1.04 26 9.32 2.64 -4.63
Issuance of Debt		 19 105 12 3.00 33 2.00 39 20 16 87
Repayment of Debt		 -0.03 -63 -0.03 -0.03 -0.03 -0.03 -0.03 -4.79 - -78
Payment of Dividends		 -11 -11 -12 -12 -12 -12 -13 -13 -13 -13
Other Financing Activities, Net		 -0.05 -0.21 -0.10 -1.01 -0.04 -0.05 -0.61 -0.06 -0.29 -0.05
Cash Interest Paid		 2.61 3.21 4.06 4.16 2.17 7.34 4.79 5.91 6.23 6.14

Annual Balance Sheets for Community Healthcare Trust

This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets		 876 945 993
Cash and Due from Banks		 11 3.49 4.38
Restricted Cash		 0.84 1.14 0.00
Loans and Leases, Net of Allowance		 0.00 0.00 0.00
Premises and Equipment, Net		 778 849 903
Other Assets		 87 91 85
Total Liabilities & Shareholders' Equity		 876 945 993
Total Liabilities		 380 432 517
Other Short-Term Payables		 11 12 14
Long-Term Debt		 353 403 486
Other Long-Term Liabilities		 15 17 16
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 497 513 476
Total Preferred & Common Equity		 497 513 476
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 497 513 476
Common Stock		 625 688 705
Retained Earnings		 -151 -192 -246
Accumulated Other Comprehensive Income / (Loss)		 23 16 18

Quarterly Balance Sheets for Community Healthcare Trust

This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 812 886 900 955 983 983 982
Cash and Due from Banks		 2.66 3.67 2.63 3.89 3.81 0.73 2.84
Restricted Cash		 0.68 0.96 1.05 1.05 1.14 0.00 0.00
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 730 797 805 852 880 899 903
Other Assets		 79 85 92 98 98 84 76
Total Liabilities & Shareholders' Equity		 812 886 900 955 983 983 982
Total Liabilities		 333 392 395 433 471 485 505
Other Short-Term Payables		 8.14 10 11 15 12 12 14
Long-Term Debt		 311 365 368 401 442 458 474
Other Long-Term Liabilities		 15 16 16 16 17 16 16
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 478 495 505 522 512 498 477
Total Preferred & Common Equity		 478 495 505 522 512 498 477
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 478 495 505 522 512 498 477
Common Stock		 602 649 657 677 691 700 702
Retained Earnings		 -145 -170 -175 -184 -201 -224 -235
Accumulated Other Comprehensive Income / (Loss)		 21 16 23 29 21 21 10

Annual Metrics And Ratios for Community Healthcare Trust

This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 7.21% 11.64% -3.40%
EBITDA Growth		 2.99% 9.06% -32.75%
EBIT Growth		 -1.61% -63.64% -139.66%
NOPAT Growth		 -1.80% -64.97% -128.87%
Net Income Growth		 -2.10% -64.97% -141.24%
EPS Growth		 -6.90% -75.31% -215.00%
Operating Cash Flow Growth		 6.98% 1.83% -4.08%
Free Cash Flow Firm Growth		 -58.75% 41.05% 19.25%
Invested Capital Growth		 16.77% 7.85% 4.95%
Revenue Q/Q Growth		 1.69% 2.41% -12.70%
EBITDA Q/Q Growth		 -0.31% 1.86% -25.01%
EBIT Q/Q Growth		 -2.99% -9.01% -113.96%
NOPAT Q/Q Growth		 9.37% 24.64% -605.32%
Net Income Q/Q Growth		 -3.82% -8.00% -613.23%
EPS Q/Q Growth		 -6.90% -4.76% -130.00%
Operating Cash Flow Q/Q Growth		 0.69% -1.79% 2.39%
Free Cash Flow Firm Q/Q Growth		 -100.50% 53.93% -71.98%
Invested Capital Q/Q Growth		 7.67% -0.76% 1.16%
Profitability Metrics		 - - -
EBITDA Margin		 64.34% 62.86% 43.76%
EBIT Margin		 25.69% 8.37% -3.43%
Profit (Net Income) Margin		 25.64% 8.05% -3.43%
Tax Burden Percent		 99.81% 96.18% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00%
Effective Tax Rate		 0.19% 3.82% 0.00%
Return on Invested Capital (ROIC)		 2.79% 0.87% -0.24%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.79% 0.87% -0.45%
Return on Net Nonoperating Assets (RNNOA)		 1.80% 0.65% -0.41%
Return on Equity (ROE)		 4.59% 1.53% -0.64%
Cash Return on Invested Capital (CROIC)		 -12.68% -6.68% -5.07%
Operating Return on Assets (OROA)		 2.71% 0.88% -0.33%
Return on Assets (ROA)		 2.70% 0.85% -0.33%
Return on Common Equity (ROCE)		 4.59% 1.53% -0.64%
Return on Equity Simple (ROE_SIMPLE)		 4.43% 1.50% -0.67%
Net Operating Profit after Tax (NOPAT)		 22 7.71 -2.23
NOPAT Margin		 25.64% 8.05% -2.40%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.21%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 74.31% 91.63% 91.56%
Earnings before Interest and Taxes (EBIT)		 22 8.02 -3.18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 55 60 41
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 1.59 1.30 1.14
Price to Tangible Book Value (P/TBV)		 1.59 1.30 1.14
Price to Revenue (P/Rev)		 9.18 6.96 5.86
Price to Earnings (P/E)		 35.82 86.48 0.00
Dividend Yield		 5.66% 7.38% 9.60%
Earnings Yield		 2.79% 1.16% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.33 1.16 1.06
Enterprise Value to Revenue (EV/Rev)		 13.15 11.12 11.06
Enterprise Value to EBITDA (EV/EBITDA)		 20.44 17.69 25.27
Enterprise Value to EBIT (EV/EBIT)		 51.20 132.88 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 51.30 138.15 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.74 17.36 17.39
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.71 0.79 1.02
Long-Term Debt to Equity		 0.71 0.79 1.02
Financial Leverage		 0.65 0.75 0.90
Leverage Ratio		 1.70 1.80 1.96
Compound Leverage Factor		 1.70 1.80 1.96
Debt to Total Capital		 41.54% 44.00% 50.52%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 41.54% 44.00% 50.52%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 58.46% 56.00% 49.48%
Debt to EBITDA		 6.39 6.69 11.99
Net Debt to EBITDA		 6.17 6.62 11.88
Long-Term Debt to EBITDA		 6.39 6.69 11.99
Debt to NOPAT		 16.03 52.28 -218.24
Net Debt to NOPAT		 15.48 51.68 -216.27
Long-Term Debt to NOPAT		 16.03 52.28 -218.24
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 -100 -59 -48
Operating Cash Flow to CapEx		 580.96% 323.39% 238.93%
Free Cash Flow to Firm to Interest Expense		 -8.43 -3.32 -2.01
Operating Cash Flow to Interest Expense		 5.08 3.45 2.48
Operating Cash Flow Less CapEx to Interest Expense		 4.20 2.38 1.44
Efficiency Ratios		 - - -
Asset Turnover		 0.11 0.11 0.10
Fixed Asset Turnover		 0.12 0.12 0.11
Capital & Investment Metrics		 - - -
Invested Capital		 850 917 962
Invested Capital Turnover		 0.11 0.11 0.10
Increase / (Decrease) in Invested Capital		 122 67 45
Enterprise Value (EV)		 1,130 1,066 1,024
Market Capitalization		 789 667 543
Book Value per Share		 $19.64 $18.83 $16.85
Tangible Book Value per Share		 $19.64 $18.83 $16.85
Total Capital		 850 917 962
Total Debt		 353 403 486
Total Long-Term Debt		 353 403 486
Net Debt		 341 399 482
Capital Expenditures (CapEx)		 10 19 25
Net Nonoperating Expense (NNE)		 0.00 0.00 0.95
Net Nonoperating Obligations (NNO)		 353 403 486
Total Depreciation and Amortization (D&A)		 33 52 44
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.81 $0.20 ($0.23)
Adjusted Weighted Average Basic Shares Outstanding		 23.63M 25.20M 26.53M
Adjusted Diluted Earnings per Share		 $0.81 $0.20 ($0.23)
Adjusted Weighted Average Diluted Shares Outstanding		 23.63M 25.20M 26.53M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 26.02M 27.68M 28.34M
Normalized Net Operating Profit after Tax (NOPAT)		 22 7.81 -2.14
Normalized NOPAT Margin		 25.64% 8.15% -2.31%
Pre Tax Income Margin		 25.69% 8.37% -3.43%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 1.86 0.45 -0.13
NOPAT to Interest Expense		 1.85 0.43 -0.09
EBIT Less CapEx to Interest Expense		 0.98 -0.62 -1.17
NOPAT Less CapEx to Interest Expense		 0.98 -0.63 -1.13
Payout Ratios		 - - -
Dividend Payout Ratio		 202.03% 623.01% -1,625.21%
Augmented Payout Ratio		 202.03% 623.01% -1,625.21%

Quarterly Metrics And Ratios for Community Healthcare Trust

This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 6.44% 6.98% 11.28% 14.38% 10.61% 10.33% 4.58% 13.94% 23.85% -55.80%
EBITDA Growth		 3.67% -1.22% 3.88% 15.92% 8.40% 7.96% -0.36% -59.49% 27.22% -95.40%
EBIT Growth		 5.46% -11.45% -225.06% 18.34% -33.00% -15.10% 153.22% -167.01% 109.62% -332.97%
NOPAT Growth		 -30.31% 272.56% -159.16% 17.45% -36.65% 69.51% 176.02% -147.27% 122.51% -58.86%
Net Income Growth		 5.96% -14.31% -225.31% 17.78% -38.45% -12.81% 152.95% -258.54% -49.91% -59.89%
EPS Growth		 5.00% -25.00% -252.38% 14.29% -47.62% -5.56% 134.38% -275.00% -63.64% -76.47%
Operating Cash Flow Growth		 15.85% 2.77% -11.83% 10.31% 15.41% -7.26% -0.43% 0.32% -21.85% 9.60%
Free Cash Flow Firm Growth		 47.30% -40.95% -459.26% -134.76% -102.95% 47.89% 26.61% 16.77% 85.16% 29.99%
Invested Capital Growth		 9.74% 16.77% 16.04% 14.22% 17.01% 7.85% 10.98% 9.38% 2.97% 4.95%
Revenue Q/Q Growth		 2.05% 0.44% 6.07% 5.21% -1.32% 0.18% 0.54% 14.63% 7.27% -64.25%
EBITDA Q/Q Growth		 0.18% -0.74% 2.85% 13.34% -6.31% -1.14% -6.36% -53.92% 194.20% -96.42%
EBIT Q/Q Growth		 1.68% -7.64% -230.96% 196.22% -42.43% 17.04% -21.50% -221.17% 280.07% -230.07%
NOPAT Q/Q Growth		 1.30% -53.57% -283.03% 236.43% -45.36% 24.23% -21.50% -184.82% 357.25% -77.03%
Net Income Q/Q Growth		 1.59% -7.67% -232.15% 195.02% -46.91% 30.78% -19.75% -384.50% 116.77% 4.75%
EPS Q/Q Growth		 0.00% -14.29% -277.78% 175.00% -54.17% 54.55% -35.29% -481.82% 109.52% 0.00%
Operating Cash Flow Q/Q Growth		 1.55% 0.38% -17.60% 31.33% 6.24% -19.33% -11.54% 32.32% -17.24% 13.14%
Free Cash Flow Firm Q/Q Growth		 -47.86% -85.57% -3.49% 17.33% -27.83% 52.36% -46.26% 6.25% 77.21% -124.77%
Invested Capital Q/Q Growth		 3.21% 7.67% 1.15% 1.61% 5.73% -0.76% 4.09% 0.15% -0.47% 1.16%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 63.83% 63.08% 61.16% 65.89% 62.55% 61.72% 58.27% 23.43% 64.25% 6.43%
EBIT Margin		 26.14% 24.03% -29.67% 27.14% 15.83% 18.50% 15.10% -15.96% 26.80% -97.49%
Profit (Net Income) Margin		 26.04% 23.94% -29.82% 26.93% 14.49% 18.92% 15.10% -37.48% 5.86% 17.17%
Tax Burden Percent		 99.63% 198.86% 100.51% 99.25% 91.53% 102.28% 100.00% 100.00% 100.29% 99.73%
Interest Burden Percent		 100.00% 50.09% 100.00% 100.00% 100.00% 100.00% 100.00% 234.79% 21.81% -17.66%
Effective Tax Rate		 0.37% 0.00% 0.00% 0.75% 5.79% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 2.92% 1.31% -2.29% 3.00% 1.63% 2.01% 1.61% -1.23% 3.03% 1.70%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.92% 2.15% -2.95% 3.00% 1.60% 2.03% 1.61% -3.00% 1.60% 1.70%
Return on Net Nonoperating Assets (RNNOA)		 1.76% 1.39% -1.94% 2.02% 1.14% 1.52% 1.30% -2.47% 1.40% 1.53%
Return on Equity (ROE)		 4.68% 2.70% -4.23% 5.03% 2.77% 3.53% 2.91% -3.69% 4.44% 3.22%
Cash Return on Invested Capital (CROIC)		 -6.62% -12.68% -13.97% -12.29% -14.95% -6.68% -8.38% -8.78% -2.96% -5.07%
Operating Return on Assets (OROA)		 2.83% 2.53% -3.18% 2.94% 1.68% 1.95% 1.57% -1.70% 2.94% -9.32%
Return on Assets (ROA)		 2.82% 2.52% -3.19% 2.92% 1.54% 1.99% 1.57% -3.99% 0.64% 1.64%
Return on Common Equity (ROCE)		 4.68% 2.70% -4.23% 5.03% 2.77% 3.53% 2.91% -3.69% 4.44% 3.22%
Return on Equity Simple (ROE_SIMPLE)		 4.78% 0.00% 1.94% 2.09% 1.61% 0.00% 3.58% 0.26% -0.09% 0.00%
Net Operating Profit after Tax (NOPAT)		 5.67 2.63 -4.82 6.58 3.59 4.47 3.67 -3.11 8.00 1.84
NOPAT Margin		 26.04% 12.04% -20.77% 26.93% 14.91% 18.50% 15.10% -11.17% 26.80% 17.22%
Net Nonoperating Expense Percent (NNEP)		 0.00% -0.84% 0.66% 0.00% 0.03% -0.03% 0.00% 1.77% 1.43% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 73.86% 75.97% 129.67% 72.86% 84.17% 81.50% 84.90% 76.43% 73.20% 197.49%
Earnings before Interest and Taxes (EBIT)		 5.69 5.26 -6.89 6.63 3.82 4.47 3.67 -4.44 8.00 -10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 14 14 14 16 15 15 14 6.52 19 0.69
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.51 1.59 1.74 1.57 1.40 1.30 1.35 1.27 1.07 1.14
Price to Tangible Book Value (P/TBV)		 1.51 1.59 1.74 1.57 1.40 1.30 1.35 1.27 1.07 1.14
Price to Revenue (P/Rev)		 8.58 9.18 9.74 8.69 7.80 6.96 7.15 6.30 4.80 5.86
Price to Earnings (P/E)		 31.64 35.82 89.79 75.12 87.07 86.48 37.65 451.84 0.00 0.00
Dividend Yield		 6.08% 5.66% 5.37% 5.92% 6.53% 7.38% 7.14% 8.00% 10.11% 9.60%
Earnings Yield		 3.16% 2.79% 1.11% 1.33% 1.15% 1.16% 2.66% 0.22% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.31 1.33 1.42 1.33 1.22 1.16 1.18 1.14 1.03 1.06
Enterprise Value to Revenue (EV/Rev)		 12.22 13.15 13.83 12.69 12.03 11.12 11.66 10.85 9.24 11.06
Enterprise Value to EBITDA (EV/EBITDA)		 18.62 20.44 21.87 19.97 19.04 17.69 23.30 21.81 18.14 25.27
Enterprise Value to EBIT (EV/EBIT)		 45.38 51.20 126.21 108.31 127.79 132.88 60.53 58.53 43.01 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 51.25 51.30 173.27 143.55 182.00 138.15 61.42 672.23 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 17.24 18.74 20.83 19.26 18.02 17.36 18.43 17.74 17.04 17.39
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.65 0.71 0.74 0.73 0.77 0.79 0.86 0.92 0.99 1.02
Long-Term Debt to Equity		 0.65 0.71 0.74 0.73 0.77 0.79 0.86 0.92 0.99 1.02
Financial Leverage		 0.60 0.65 0.66 0.67 0.71 0.75 0.80 0.82 0.88 0.90
Leverage Ratio		 1.66 1.70 1.71 1.72 1.77 1.80 1.86 1.88 1.94 1.96
Compound Leverage Factor		 1.66 0.85 1.71 1.72 1.77 1.80 1.86 4.41 0.42 -0.35
Debt to Total Capital		 39.38% 41.54% 42.47% 42.15% 43.44% 44.00% 46.37% 47.90% 49.82% 50.52%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 39.38% 41.54% 42.47% 42.15% 43.44% 44.00% 46.37% 47.90% 49.82% 50.52%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 60.62% 58.46% 57.53% 57.85% 56.56% 56.00% 53.63% 52.10% 50.18% 49.48%
Debt to EBITDA		 5.61 6.39 6.54 6.35 6.78 6.69 9.12 9.16 8.77 11.99
Net Debt to EBITDA		 5.55 6.17 6.46 6.28 6.70 6.62 9.02 9.15 8.71 11.88
Long-Term Debt to EBITDA		 5.61 6.39 6.54 6.35 6.78 6.69 9.12 9.16 8.77 11.99
Debt to NOPAT		 15.44 16.03 51.85 45.63 64.82 52.28 24.04 282.48 -1,500.53 -218.24
Net Debt to NOPAT		 15.27 15.48 51.19 45.17 64.03 51.68 23.77 282.03 -1,491.54 -216.27
Long-Term Debt to NOPAT		 15.44 16.03 51.85 45.63 64.82 52.28 24.04 282.48 -1,500.53 -218.24
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -64 -119 -124 -102 -131 -62 -91 -85 -19 -44
Operating Cash Flow to CapEx		 503.31% 418.98% 306.86% 445.17% 495.30% 190.05% 247.27% 232.83% 192.69% 303.51%
Free Cash Flow to Firm to Interest Expense		 -21.26 -34.48 -30.97 -24.68 -28.15 -12.40 -17.92 0.00 0.00 -2.34
Operating Cash Flow to Interest Expense		 5.07 4.45 3.18 4.03 3.82 2.85 2.50 0.00 0.00 0.84
Operating Cash Flow Less CapEx to Interest Expense		 4.06 3.39 2.14 3.12 3.05 1.35 1.49 0.00 0.00 0.56
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.11 0.11 0.11 0.11 0.11 0.11 0.10 0.11 0.11 0.10
Fixed Asset Turnover		 0.08 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.11
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 789 850 860 873 923 917 954 955 951 962
Invested Capital Turnover		 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0.10
Increase / (Decrease) in Invested Capital		 70 122 119 109 134 67 94 82 27 45
Enterprise Value (EV)		 1,032 1,130 1,220 1,158 1,126 1,066 1,130 1,089 980 1,024
Market Capitalization		 724 789 860 794 730 667 693 632 509 543
Book Value per Share		 $19.06 $19.64 $19.00 $19.21 $19.67 $18.83 $19.46 $17.97 $17.01 $16.85
Tangible Book Value per Share		 $19.06 $19.64 $19.00 $19.21 $19.67 $18.83 $19.46 $17.97 $17.01 $16.85
Total Capital		 789 850 860 873 923 917 954 955 951 962
Total Debt		 311 353 365 368 401 403 442 458 474 486
Total Long-Term Debt		 311 353 365 368 401 403 442 458 474 486
Net Debt		 307 341 360 364 396 399 437 457 471 482
Capital Expenditures (CapEx)		 3.05 3.68 4.14 3.75 3.58 7.52 5.11 7.19 7.19 5.16
Net Nonoperating Expense (NNE)		 0.00 -2.60 2.10 0.00 0.10 -0.10 0.00 7.32 6.25 0.01
Net Nonoperating Obligations (NNO)		 311 353 365 368 401 403 442 458 474 486
Total Depreciation and Amortization (D&A)		 8.21 8.54 21 9.46 11 10 10 11 11 11
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.21 $0.18 ($0.32) $0.24 $0.11 $0.17 $0.11 ($0.42) $0.04 $0.04
Adjusted Weighted Average Basic Shares Outstanding		 23.59M 23.63M 24.23M 25.07M 25.51M 25.20M 26.30M 26.48M 26.66M 26.53M
Adjusted Diluted Earnings per Share		 $0.21 $0.18 ($0.32) $0.24 $0.11 $0.17 $0.11 ($0.42) $0.04 $0.04
Adjusted Weighted Average Diluted Shares Outstanding		 23.59M 23.63M 24.23M 25.07M 25.51M 25.20M 26.30M 26.48M 26.66M 26.53M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.30M 26.02M 26.30M 26.56M 27.26M 27.68M 27.70M 28.06M 28.24M 28.34M
Normalized Net Operating Profit after Tax (NOPAT)		 5.67 1.84 -4.82 6.58 3.59 3.13 2.57 -3.01 5.60 1.29
Normalized NOPAT Margin		 26.04% 8.43% -20.77% 26.93% 14.91% 12.95% 10.57% -10.82% 18.76% 12.05%
Pre Tax Income Margin		 26.14% 12.04% -29.67% 27.14% 15.83% 18.50% 15.10% -37.48% 5.84% 17.22%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 1.88 1.52 -1.73 1.60 0.82 0.89 0.72 0.00 0.00 -0.56
NOPAT to Interest Expense		 1.87 0.76 -1.21 1.59 0.77 0.89 0.72 0.00 0.00 0.10
EBIT Less CapEx to Interest Expense		 0.87 0.46 -2.76 0.70 0.05 -0.61 -0.29 0.00 0.00 -0.83
NOPAT Less CapEx to Interest Expense		 0.87 -0.30 -2.24 0.68 0.00 -0.61 -0.29 0.00 0.00 -0.18
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 192.50% 202.03% 471.76% 435.05% 559.51% 623.01% 268.28% 3,858.67% -11,430.72% -1,625.21%
Augmented Payout Ratio		 192.50% 202.03% 471.76% 435.05% 559.51% 623.01% 268.28% 3,858.67% -11,430.72% -1,625.21%

Financials Breakdown Chart

Key Financial Trends

Community Healthcare Trust (NYSE: CHCT) has shown notable financial trends over the last four years, encompassing Q3 and Q4 of 2022 through Q4 2024. Below is an analysis of key financial metrics and observations:

  • Consistent net income recovery: After experiencing net losses in early 2023 (notably Q1 and Q2 2023), CHCT has returned to profitability starting Q3 2023, sustained through 2024. Q4 2024 net income was positive at $1.83 million, indicating operational improvement.
  • Increasing total revenues and non-interest income: Total revenue increased from roughly $21.88 million in Q4 2022 to $29.3 million+ in several 2024 quarters; non-interest income remains a strong contributor (~$27 million+ per quarter), supporting diversified income streams beyond interest.
  • Strong operating cash flow generation: Net cash from operating activities stayed robust, ranging from ~$12.6 million in early 2023 quarters to $15.7 million in Q4 2024, supporting daily operations and investments.
  • Steady investments in property and equipment: Capital expenditures (property, leasehold improvements) averaged between $5 million to over $7 million per quarter in 2024, reflecting ongoing investment in asset base.
  • Dividend payments persist: Despite fluctuations in earnings, CHCT maintained and slightly increased dividend payments per share in 2024 quarters, currently around $0.46 per share quarterly, appealing to income-focused investors.
  • Equity base remains solid: Total common equity stayed stable around $477 million in Q3 2024, supporting balance sheet strength.
  • Net interest income volatility: Net interest income showed high variability, including a large negative swing in Q4 2024 (-$18.6 million) due to significantly high total interest expense ($18.6 million) compared to minimal interest income ($16,000), which could be linked to interest on debt or financing costs.
  • Long-term debt fluctuations: The balance sheet reveals an increase in long-term debt from ~$365 million in Q1 2023 to $474 million by Q3 2024, showing that the company has been raising debt for financing purposes.
  • Large interest expense impacting earnings: Interest expense steadily rose year-over-year, reaching $18.6 million in Q4 2024; this has materially pressured net interest income and overall profitability.
  • Non-interest expenses high and rising: Non-interest expenses such as property & liability insurance claims, depreciation, and other operating expenses total about $21 million in Q4 2024, higher than prior periods, which compresses earnings margins.

Summary: Community Healthcare Trust has demonstrated resilience, recovering from negative earnings in early 2023 to steady profitability by late 2023 and through 2024. Strong cash flows and steady dividends reinforce operational stability. However, rising interest expenses and non-interest costs remain challenges, reflecting increased leverage and operational costs. Investors should watch how CHCT manages its interest expenses and continues to grow revenues while controlling costs.

09/18/25 02:47 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Community Healthcare Trust's Financials

When does Community Healthcare Trust's fiscal year end?

According to the most recent income statement we have on file, Community Healthcare Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Community Healthcare Trust's net income changed over the last 2 years?

Community Healthcare Trust's net income appears to be on a downward trend, with a most recent value of -$3.18 million in 2024, falling from $22.02 million in 2022. The previous period was $7.71 million in 2023. See Community Healthcare Trust's forecast for analyst expectations on what’s next for the company.

How has Community Healthcare Trust's revenue changed over the last 2 years?

Over the last 2 years, Community Healthcare Trust's total revenue changed from $85.87 million in 2022 to $92.61 million in 2024, a change of 7.8%.

How much debt does Community Healthcare Trust have?

Community Healthcare Trust's total liabilities were at $516.60 million at the end of 2024, a 19.5% increase from 2023, and a 36.1% increase since 2022.

How much cash does Community Healthcare Trust have?

In the past 2 years, Community Healthcare Trust's cash and equivalents has ranged from $3.49 million in 2023 to $11.23 million in 2022, and is currently $4.38 million as of their latest financial filing in 2024.

How has Community Healthcare Trust's book value per share changed over the last 2 years?

Over the last 2 years, Community Healthcare Trust's book value per share changed from 19.64 in 2022 to 16.85 in 2024, a change of -14.2%.


Related Companies

This page (NYSE:CHCT) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners
REVEALED: Something Big Happening Behind White House Doors
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
Crypto Gets Official Government Backing—Here's the Winner
Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...
Crypto 101 Media | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
College grad makes $64,000 a month
A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...
Stansberry Research | Sponsoredtc pixel
Warren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the Nasdaq
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...
Altimetry | Sponsoredtc pixel
Alert: Prepare for Trump's Dollar Overhaul
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...
Brownstone Research | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel
Front-Run Buffett's Shocking Gold Move
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsoredtc pixel